Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Compositional recombination is facilitated by a distributed cortico-cerebellar network.

Cell reports·2026
Same author

Feasibility of Internet-Based Mind-Body Training for Adults With Subjective Cognitive Decline: Protocol for a Randomized Controlled Trial.

JMIR research protocols·2026
Same author

Training a Lens on the Locus Coeruleus-Noradrenergic System in Late-Life Depression.

Biological psychiatry. Cognitive neuroscience and neuroimaging·2026
Same author

Seeing through the static: Reduced imagery vividness in aphantasia is associated with impaired temporal lobe signal complexity.

Neuropsychologia·2025
Same author

Susceptibility to visual hallucinations in the amyotrophic lateral sclerosis-frontotemporal dementia spectrum: The role of dysfunctional attentional networks.

Cortex; a journal devoted to the study of the nervous system and behavior·2025
Same author

Noradrenergic therapies in neurodegenerative disease: from symptomatic to disease modifying therapy?

Brain communications·2025

Related Experiment Video

Updated: May 20, 2026

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
12:28

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Published on: June 3, 2020

Inhibitory dysfunction in frontotemporal dementia: a review.

Claire O'Callaghan1, John R Hodges, Michael Hornberger

  • 1Neuroscience Research Australia, University of New South Wales, Sydney, NSW, Australia.

Alzheimer Disease and Associated Disorders
|July 26, 2012
PubMed
Summary
This summary is machine-generated.

Frontotemporal dementia (FTD) patients show early inhibitory control failure due to orbitofrontal cortex damage. Nonverbal tasks may improve diagnosis by assessing this dysfunction.

More Related Videos

Combined Peripheral Nerve Stimulation and Controllable Pulse Parameter Transcranial Magnetic Stimulation to Probe Sensorimotor Control and Learning
14:47

Combined Peripheral Nerve Stimulation and Controllable Pulse Parameter Transcranial Magnetic Stimulation to Probe Sensorimotor Control and Learning

Published on: April 21, 2023

Related Experiment Videos

Last Updated: May 20, 2026

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
12:28

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Published on: June 3, 2020

Combined Peripheral Nerve Stimulation and Controllable Pulse Parameter Transcranial Magnetic Stimulation to Probe Sensorimotor Control and Learning
14:47

Combined Peripheral Nerve Stimulation and Controllable Pulse Parameter Transcranial Magnetic Stimulation to Probe Sensorimotor Control and Learning

Published on: April 21, 2023

Area of Science:

  • Neuroscience
  • Clinical Psychology
  • Neurology

Background:

  • Inhibitory control deficits are an early hallmark of frontotemporal dementia (FTD).
  • Ventromedial prefrontal cortex atrophy, especially in the orbitofrontal cortex, underlies this dysfunction.
  • Current assessment methods for inhibitory processes in FTD are limited and can be confounded by language deficits.

Purpose of the Study:

  • To explore inhibitory functioning in FTD using nonverbal experimental tasks.
  • To address the limitations of existing neuropsychological assessments for FTD.
  • To improve the characterization of early inhibitory dysfunction for more accurate FTD diagnosis.

Main Methods:

  • Review of existing literature on inhibitory control in FTD.
  • Discussion of limitations of current behavioral and neuropsychological assessments.
  • Proposal of nonverbal experimental tasks as a viable clinical tool.

Main Results:

  • Inhibitory dysfunction is a consistent early feature in FTD, linked to orbitofrontal cortex atrophy.
  • Caregiver reports vary, and existing neuropsychological tests may be confounded by language impairments.
  • Nonverbal tasks offer a promising alternative for assessing inhibitory control in FTD.

Conclusions:

  • Nonverbal experimental tasks represent a promising avenue for assessing early inhibitory dysfunction in FTD.
  • Improved characterization of inhibitory deficits may lead to earlier and more accurate FTD diagnosis.
  • This approach could help elucidate the role of orbitofrontal cortex dysfunction in FTD.